Psyence Biomedical Ltd. Made Headway
Wed, May 01, 2024 at 07:21 PM
Psyence Biomedical Ltd. (PBM:NASDAQ) jumped higher at $1.2, a gain of 33.4%. On Wed, May 01, 2024, PBM:NASDAQ hit a New 2-Week High of $1.2. The stock got featured on our News Catalysts scanner on Wed, Apr 17, 2024 at 10:38 AM in the 'BIOTECH' category. From Wed, Apr 17, 2024, the stock recorded 70.00% Up Days and 63.64% Green Days
The stock spiked on Fri, Mar 08, 2024 at $4.31 with a volume of 149M+.
About Psyence Biomedical Ltd. (PBM:NASDAQ)
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa.
Top 10 Gainers:
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 214.72%
- SYLA Technologies Co. Ltd. (SYT:NASDAQ), 122.45%
- The Real Good Food Company Inc. (RGF:NASDAQ), 73.14%
- BioAtla Inc. (BCAB:NASDAQ), 49.45%
- Latch Inc. (LTCH:NASDAQ), 37.97%
- Aptevo Therapeutics Inc. (APVO:NASDAQ), 35.08%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 33.41%
- a.k.a. Brands Holding Corp. (AKA:NYSE), 31.63%
- Mediaco Holding Inc. (MDIA:NASDAQ), 30.68%
- Surmodics, Inc. (SRDX:NASDAQ), 29.74%